In a study published in PNAS, scientists reveal how desert ants compensate for visual loss through a rapid relearning process. These findings could inspire technological advancements to improve ...

The word “transient” may be defined as being temporary or momentary. Transient visual loss is a reversible symptom of a number of possible underlying diseases. It can be defined by its ...

The Case: A 40-year-old man was referred because of multiple events of transient monocular visual loss since adolescence. He described the events as small, translucent, grey-coloured spots similar to ...

Visual Networks Inc. of Rockville yesterday reported a second-quarter loss of $12.3 million (39 cents per share), a significant improvement over its loss of $42.3 million ($1.54) for the same ...

A 43-year-old woman noted multiple episodes of transient visual loss on the right side. She initially thought that the episodes were in the right eye, but after cross-covering during the most ...

A pattern of visual loss may be predicted from the fellow eye in patients with bilateral sequential nonarteritic anterior optic neuropathy, according to a study. In a retrospective review, visual ...

However, measles can cause serious eye damage and visual loss. How does measles affect the eyes? Measles can infect the cornea which is the transparent tissue in front of the eye.

Important insights into the mechanisms behind Fuchs endothelial corneal dystrophy (FECD), a common cause of age-related ...

Q. Since my eyes started to go, I’ve been hallucinating and I’m afraid to tell anyone about it. Any ideas? A. Hallucinations can be a symptom of a variety of problems – both physical and mental.

Background Patients with non-organic visual loss (NOVL) can take up a disproportionate amount of clinic time and clinicians often resort to expensive and prolonged investigations to ensure the ...

Comment. The search for the lesion(s) was targeted to the visual pathways posterior to the LGN, because there was bilateral visual loss with normal pupillary light reflexes.

In PKC-DRS2, the efficacy of the oral PKC-β inhibitor, ruboxistaurin 32 mg/day, was measured by the primary end point of sustained moderate visual loss (SMVL: a ⩾15 letter decrease from ...